Epicentre Health Research: Company Profile

Background

Epicentre Health Research is a non-profit organization established in 1986 by Médecins Sans Frontières (MSF) to conduct field epidemiology, medical research, and training. Its mission is to describe and analyze the health situations of populations assisted by MSF medical teams to better orient programs and to evaluate and compare new care practices designed for populations living in unstable conditions or with insufficient access to care. Epicentre operates in complex and often unstable environments, focusing on improving access to quality healthcare for vulnerable populations.

Key Strategic Focus

Epicentre's strategic focus includes:

• Core Objectives: Conducting field epidemiology, medical research, and training to support MSF's humanitarian missions.

• Areas of Specialization: Infectious diseases such as malaria, tuberculosis, HIV, cholera, Ebola, yellow fever, neglected diseases like visceral leishmaniasis, human African trypanosomiasis, Buruli ulcer, and chronic diseases on the rise in African countries, such as cancer.

• Key Technologies Utilized: Epidemiological methods, data science tools, and Good Clinical Laboratory Practice (GCLP) accredited laboratories.

• Primary Markets or Conditions Targeted: Populations in unstable situations or with inadequate access to healthcare, including those affected by conflicts, epidemics, and disasters.

Financials and Funding

In 2022, Epicentre's funding was composed of:

• MSF's Own Fundraising Activities: Approximately two-thirds of the funding.

• External Donors: Approximately one-third of the funding.

This diversified funding model supports Epicentre's independence and ability to set its own research priorities.

Pipeline Development

Epicentre's pipeline development focuses on:

• Key Pipeline Candidates: Vaccines, diagnostics, and therapeutic solutions for infectious and neglected diseases.

• Stages of Clinical Trials or Product Development: Late-stage developmental (phases II/III) and post-registration studies.

• Target Conditions: Infectious diseases, neglected diseases, and chronic diseases prevalent in unstable settings.

• Relevant Timelines for Anticipated Milestones: Ongoing studies with results disseminated through publications and reports.

Technological Platform and Innovation

Epicentre employs several technological platforms and innovations:

• Proprietary Technologies: Development of monitoring software like "Follow Up Care HIV Aids (FUCHIA)" for patient follow-up in AIDS treatment programs.

• Significant Scientific Methods: Epidemiological surveys, data science tools, and GCLP accredited laboratories.

• AI-Driven Capabilities: Implementation of dashboards to monitor epidemics such as Ebola, measles, and malnutrition worldwide.

Leadership Team

Epicentre's leadership team comprises professionals with expertise in epidemiology, public health, and humanitarian aid. Specific names and positions are not publicly disclosed. The team is responsible for overseeing research projects, training programs, and operational support for MSF missions.

Competitor Profile

Market Insights and Dynamics

The market for health research in complex humanitarian emergencies is characterized by:

• Market Size and Growth Potential: Growing demand for research to inform humanitarian responses to epidemics, conflicts, and disasters.

• Industry Trends: Increased focus on data science, real-time monitoring, and collaboration with international health organizations.

Competitor Analysis

Key competitors in the field include:

• World Health Organization (WHO): Conducts global health research and provides technical assistance in emergencies.

• Centers for Disease Control and Prevention (CDC): Engages in global health research and emergency response.

• Other Non-Governmental Organizations (NGOs): Various NGOs conduct health research in humanitarian settings.

Epicentre differentiates itself through its close integration with MSF's operational teams, enabling rapid and context-specific research.

Strategic Collaborations and Partnerships

Epicentre collaborates with:

• MSF: Primary partner for field operations and research priorities.

• Local Health Authorities: Ensures relevance and scalability of research.

• International Health Organizations: Collaborates on global health initiatives and research projects.

Operational Insights

Epicentre's strategic considerations include:

• Major Competitors: WHO, CDC, and other NGOs.

• Market Position: Unique position as a research entity embedded within MSF, providing direct support to field operations.

• Competitive Advantages: Rapid response capabilities, integration with MSF's missions, and focus on vulnerable populations.

Strategic Opportunities and Future Directions

Epicentre's strategic roadmap includes:

• Expanding and Diversifying Expertise: Strengthening research capabilities in emerging health threats.

• Consolidating Position: Enhancing integration with MSF and other partners.

• Strengthening Regional Roots: Building capacity in local research centers in Niger and Uganda.

• Opening to Development Opportunities: Engaging with new partners to broaden the scope and impact of programs.